儿童急性巨核细胞白血病的分子特征的进展与唐氏综合征无关;对治疗发展的影响
Jixia Li1,2, Maggie L Kalev-Zylinska1,3
1Blood and Cancer Biology Laboratory, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Frontiers in cell and developmental biology
|June 16, 2023
概括
没有唐氏综合征的儿童急性大核细胞白血病 (AMKL) 具有独特的遗传特征和不良预后. 这些高风险儿童需要新的治疗方法,需要进一步的研究和多中心研究.
科学领域:
- 血液学 血液学 血液学
- 儿科瘤学 儿科瘤学
- 分子生物学分子生物学
背景情况:
- 急性巨核细胞白血病 (AMKL) 是一种罕见的急性髓性白血病 (AML) 亚型.
- 儿科AMKL影响幼儿,基于唐氏综合征 (DS) 存在的独特特征.
- 没有DS的AMKL通常呈现出嵌合基因和不良预后.
研究的目的:
- 为了总结儿科非DS AMKL的独特特征.
- 突出针对高风险患者的新疗法发展.
- 强调对儿科AMKL进一步研究的需要.
主要方法:
- 本综述综合了有关儿科非DSAMKL的当前文献.
- 专注于分子特征和预后因素.
- 检查新兴的治疗策略.
主要成果:
- 没有DS的儿科AMKL的特点是特定的复发性融合基因.
- 这些遗传变化与不良预后有关.
- 由GATA1突变驱动的DS的AMKL通常具有有利的结果.
结论:
- 儿科非DS AMKL需要通过大规模的多中心研究进行进一步的分子表征.
- 改进疾病模型的开发对于测试新疗法至关重要.
- 有针对性的治疗策略对于改善高风险儿科AMKL患者的治疗结果至关重要.
关键词:
急性巨核细胞性白血病 (AMKL)急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.虚构的合并 虚构的合并细胞遗传学 细胞遗传学基因组学就是基因组学.非唐氏综合征的AMKL.治疗目标是治疗的目标.翻译学 翻译学 翻译学 翻译学更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.5K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K